{"title":"National strategic advocacy to manage patients with inherited bleeding disorders in low and lower-middle income countries","authors":"Ampaiwan Chuansumrit, Theera Ruchutrakul, Nongnuch Sirachainan, Pimpun Kitpoka, Monratta Panuwannakorn, Panyu Panburana, Monthon Suwannuraks, Nantana Sri-Udomporn, Chusak Kijkunasathian, Suphaneewan Jaovisidha, Chirawat Utamakul, Rungrote Natesirinilkul, Bunchoo Pongtanakul, Chanchai Traivaree, Patcharee Komvilaisak, Ekawat Suwantaroj, Darintr Sosothikul, Pantep Angchaisuksiri, Ponlapat Rojnuckarin","doi":"10.1080/17474086.2023.2293092","DOIUrl":null,"url":null,"abstract":"Inherited bleeding disorders (IBDs) including hemophilia, von Willebrand disease, platelet disorders, mucocutaneous bleeding disorders and coagulation factor deficiencies are rarely found and under...","PeriodicalId":12325,"journal":{"name":"Expert Review of Hematology","volume":"9 1","pages":""},"PeriodicalIF":2.3000,"publicationDate":"2023-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Review of Hematology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/17474086.2023.2293092","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Inherited bleeding disorders (IBDs) including hemophilia, von Willebrand disease, platelet disorders, mucocutaneous bleeding disorders and coagulation factor deficiencies are rarely found and under...
期刊介绍:
Advanced molecular research techniques have transformed hematology in recent years. With improved understanding of hematologic diseases, we now have the opportunity to research and evaluate new biological therapies, new drugs and drug combinations, new treatment schedules and novel approaches including stem cell transplantation. We can also expect proteomics, molecular genetics and biomarker research to facilitate new diagnostic approaches and the identification of appropriate therapies. Further advances in our knowledge regarding the formation and function of blood cells and blood-forming tissues should ensue, and it will be a major challenge for hematologists to adopt these new paradigms and develop integrated strategies to define the best possible patient care. Expert Review of Hematology (1747-4086) puts these advances in context and explores how they will translate directly into clinical practice.